A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy
Miki Ando(Tokyo University of Science), Hiromitsu Nakauchi(University of Tsukuba), Manami Ohtaka(National Institute of Advanced Industrial Science and Technology), Satoshi Takahashi(Tokyo University of Science), Ai Kawana‐Tachikawa(Tokyo University of Science), Satoshi Yamazaki(Institute for Stem Cell Biology and Regenerative Medicine), Malcolm K. Brenner(Houston Methodist), Ken Nishimura(University of Tsukuba), Scott R. Burrows(Australian National University), Toshinobu Nishimura(Stanford University), Yasunori Ota(Tokyo University of Science), Yusuke Nakauchi(Stanford University), Tomoyuki Yamaguchi(The University of Tokyo), John J. Miles(University of Cambridge), Jun Ando(Juntendo University), Tomonari Hayama(The University of Tokyo), Mahito Nakanishi(National Institute of Advanced Industrial Science and Technology)
Cited by 86
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease
|The Journal of Experimental Medicine|2004|390
Development of Defective and Persistent Sendai Virus Vector
|Journal of Biological Chemistry|2010|373